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ABSTRACT: Metal ion binding is exploited by proteins
in nature to catalyze reactions, bind molecules, and favor
discrete structures, but it has not been demonstrated in β-
peptides or their assemblies. Here we report the design,
synthesis, and characterization of a β-peptide bundle that
uniquely binds two Cd(II) ions in a distinct bicoordinate
array. The two Cd(II) ions bind with positive allosteric
cooperativity and increase the thermodynamic stability of
the bundle by more than 50 °C. This system provides a
unique, synthetic context to explore allosteric regulation
and should pave the way to sophisticated molecular
assemblies with catalytic and substrate-sensing functions
that have historically not been available to de novo
designed synthetic proteomimetics in water.
Synthetic β3-peptide oligomers possessing a spectrum ofbiomimetic properties have been reported.1−13 These
properties include the formation of ordered, monomeric helices
in water1 that interact selectively with helix-binding clefts on
native proteins2,14,15 and protein partnerships.4 Others include
that of self-assembly5 into cooperatively folded, thermally
stable, octameric or tetrameric helical bundles.6−8 β3-peptide
bundles possessing incipient catalytic activity have also been
reported, including the ability to sequester polyols,11 catalyze
esterolysis,12 and promote the aldol reaction, all in water.
Peptoid bundles that bind Zn(II) have also been reported,16 as
have purely β-peptide assemblies that form nanotubes17 and
complex shapes,18 promote a retro-aldol reaction,9 and
contribute to a hybrid protein chemokine19 and catalyst.13
Higher-order assemblies containing both α- and β-amino acids
have also been reported.15 Each of these properties is
emblematic of proteins found in nature, and their embodiment
within a wholly synthetic scaffold demonstrates a growing
understanding of how to imbue complex function into
nonbiological macromolecules, natural or otherwise, and in
water.20
One complex function hitherto undocumented in β3-peptides
bundles is metal ion binding, although a β-peptide hairpin that
coordinates Zn(II) has been reported by Seebach.21 Natural
biomolecules exploit metal ions for chemical catalysis,
molecular recognition, energy generation, and to favor discrete
structures.22 Indeed, the preparation of structurally distinct
metallo-proteins and catalysts is a foundational objective of de
novo protein design.23 Here, we describe the design, synthesis,
and characterization of Zwit YK-C, a β3-peptide bundle that
binds two Cd2+ ions in a distinct bicoordinate array with high
affinity and positive cooperativity. This work provides a unique,
synthetic context to explore allosteric regulation, and adds a
highly complex function, allosteric metal ion binding, to the
spectrum of biomimetic activities associated with the β3-peptide
bundle fold.
The design of Zwit YK-C was guided by the previously
reported structure of Zwit-YK (Figure 1A), a β3-peptide bundle
possessing well-ordered tertiary structure and superior thermal
stability,10 and the large body of research on α-peptide
assemblies that bind Cd(II).24 Examination of the Zwit-YK
X-ray structure suggested that addition of a single β-
homocysteine (β-Cys) residue to the Zwit-YK C-terminus
would result in an octameric bundle containing two or four
copies of two stereochemically and electrostatically distinct
two-coordinate metal binding sites (Figure 1B,C). One site is
formed at the termini of two parallel helices and is repeated
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Figure 1. (A) Ribbon diagram of the previously reported Zwit-YK β-
peptide bundle structure determined by X-ray crystallography.10 The
locations of the N- and C-termini of each strand are indicated by cyan
and red coloring, respectively. Close-up of the potential two-
coordinate Cd2+ binding site formed at the (B) parallel and (C)
perpendicular helix interface in a model of the Zwit-YK-C octameric
bundle. The perpendicular interface is rotated 40 degrees for clarity.
(D) Primary sequence of Zwit-YK-C monomer.
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four times per bundle; the other is formed at the perpendicular
interface of two helices from opposite halves of the bundle, and
is repeated twice. Placing the β-Cys residue at the C-terminus
also avoids self-cleavage events that can potentially occur with
internal β-Cys residues. To evaluate this design, we prepared
Zwit YK-C (Figure 1D) using standard solid phase methods
and characterized its affinity for various metal ions.
In the absence of metal ions, Zwit YK-C assembles into a β-
peptide octamer whose biophysical properties resemble those
of Zwit YK10 and previous β-peptide bundles (Figure 2).6,7,10,12
The CD spectrum of Zwit YK-C at a concentration where the
monomer predominates (5 μM) is characterized by the
expected negative ellipticity (ε) between 205 and 215 nm.
The signal in this region increases gradually as the
concentration increases to 200 μM (Figure 2A). The
concentration-dependent changes in ellipticity at 210 nm
(ε210) fit well to a monomer-octamer equilibrium (ln Ka = 85.4
± 0.15; R2 = 0.9992) (Figure 2B). Sedimentation equilibrium
analytical ultracentrifugation experiments (Figure 2C,D)
further support the assembly of Zwit-YK-C into an octamer
(n = 7.88 ± 0.10, RMSD = 0.0061) whose affinity constant (ln
Ka = 85.09 ± 1.4) matches the value estimated by CD. Fits to
bundle stoichiometries other than 8 were notably poorer
(Figure 2D). The thermodynamic stability of the Zwit YK-C
octamer is lower than that of the Zwit-YK octamer (ln Ka =
94.2 ± 0.3)10 but higher than that of Zwit-1F (ln Ka = 71.0),
indicating that a C-terminal residue is tolerated by the
octameric fold.6
In preparation for investigating thiolate-mediated metal ion
binding by the Zwit YK-C bundle, we synthesized a short test
peptide containing two β-Cys residues, β-YACAACA, and
spectroscopically monitored its interactions with metal ions.
Incubation of 200 μM β-YACAACA with Hg2+, Pb2+, Zn2+, and
Cd2+ led to characteristic ligand-to-metal charge transfer
(LMCT) bands only in the presence of Cd2+.25 At [Cd2+] ≤
50 μM, the UV−vis spectrum exhibited an absorbance
maximum at 250 nm, consistent with formation of a four-
coordinate thiolate complex.26,27 At [Cd2+] ≥ 150 μM, the
UV−vis spectrum exhibited an absorbance maximum at <230
nm, consistent with two-coordinate thiolate binding (Figure
3A).27
We then performed analogous titrations to explore metal ion
binding by the Zwit YK-C octamer. We treated 100 μM Zwit
YK-C (where 95% of [Zwit YK-C]T is structured in a bundle at
equilibrium) with μM to mM concentrations of Cd2+ (Figure
3B), Hg2+, Ni2+, Pb2+, and Zn2+. Treatment of Zwit YK-C with
Hg2+ and Pb2+ resulted in irreversible peptide aggregation,
while treatment with Ni2+ and Zn2+ led to negligible additional
UV absorbance (data not shown). As with the test peptide,
however, addition of between 10 and 75 μM Cd2+ led to the
appearance of LMCT bands at <230 nm, indicating two-
coordinate binding of Cd2+ (Figure 3B). At no concentration
tested did the spectra reveal the local maximum at 250 nm that
characterizes 4-coordinate binding.
As described above, the D2 symmetry that characterizes β-
peptide bundles such as Zwit YK begets two distinct, potential
Cd2+ binding sites: one (the “parallel site”) repeated four times,
the other (the “perpendicular site”) repeated twice (Figure 1).
These sites are not identical: examination of the parental Zwit-
Figure 2. Circular dichroism (CD) and sedimentation equilibrium
analytical ultracentrifugation (SE-AU) analysis of β-peptide bundle
formation by Zwit YK-C in TT buffer (5 mM Tris-Cl (pH 8), 1 mM
TCEP). (A) Wavelength-dependent CD spectra of Zwit YK-C (25
°C) at concentrations between 1.6 and 200 μM. (B) Plot of the MRE
at 210 nm as a function of [Zwit YK-C]T and fit to an ideal monomer-
ocatamer equilibrium. (C) SE-AU analysis of Zwit-YK-C at 120 μM in
TT buffer containing 100 mM NaCl, fit to a monomer-octamer
equilibrium. (D) RMSD of the SE-AU fits as a function of n.
Figure 3. Plots illustrating Cd2+ binding by (A) β-YACAACA and (B−
D) the Zwit YK-C β3-peptide bundle. (A) UV−vis difference spectra
of β-YACAACA (200 μM) in the presence of high (200 μM) or
moderate (50 μM) Cd2+, normalized to show the shift in LMCT
signal. (B) UV−vis difference spectra of Zwit YK-C (100 μM) as the
[Cd2+] varies between 0 and 75 μM. (C) Plot of absorbance at 245 nm
of 50 μM Cd2+ as a function of added [Zwit YK-C]T showing a plateau
at 4 equiv of [Zwit YK-C]T. (D) Temperature-dependent CD spectra
illustrating cooperative unfolding of the Zwit YK-C bundle ([Zwit YK-
C]T = 100 μM) both alone (Tm = 41.5 °C) and in the presence of 30
μM CdCl2 (Tm > 90 °C).
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YK bundle structure reveals two neighboring β-Glu residues in
proximity to the perpendicular site, whereas the parallel site is
impinged upon by a β-Tyr residue from another helix within
the bundle. This analysis suggests that the Zwit YK-C bundle
should bind 2 or 4 Cd2+ ions at saturation if the perpendicular
or parallel sites are preferred, respectively.
We performed a reverse titration to determine the number of
Cd2+ ions bound per Zwit TK-C bundle (Figure 3C). This
experiment was performed using 50 μM Cd2+ and between 100
and 500 μM [Zwit YK-C]T ensuring virtually complete (>95%)
bundle formation at every titration stage. The absorbance
corresponding to the LMCT band at 245 nm increased linearly
between 2 and 4 equiv [Zwit YK-C]T and then plateaued. The
position of the plateau, at 4 equiv [Zwit YK-C]T, indicates a
stoichiometry of two Cd2+ sites per octameric bundle. This
stoichiometry is most consistent with occupancy of the
perpendicular site, repeated twice per octamer. The details of
the observed binding, however, including the potential for
neighboring carboxylate ligation, is unknown at this time and
awaits high resolution study.
The 2:1 Cd2+:bundle stoichiometry, combined with the
observed two-coordinate Cd−S binding, also implies that each
Cd2+ ion must bridge two Zwit YK-C monomers. If so, one
would expect that addition of Cd2+ would increase bundle
thermodynamic stability, shifting the temperature at which
cooperative unfolding occurs. Indeed, temperature-dependent
CD experiments revealed that in the absence of added metal
ion, the Zwit YK-C bundle unfolds cooperatively at roughly 40
°C; evaluation of the first derivative of the temperature-
dependent ellipticity change at 210 nm revealed a Tm of 41.5
°C. In the presence of 30 μM Cd2+ (a saturating concentration
for 100 μM [Zwit YK-C]T), however, the ellipticity at 210 nm
increases gradually at temperatures greater than 40 °C and does
not indicate full unfolding, even at temperatures greater than 90
°C (Figure 3D). The large (>50 °C) increase in Tm observed in
the presence of Cd2+ indicates a significant improvement in the
thermodynamic stability of the quaternary fold, consistent with
simultaneous binding of two Cd2+ to two pairs of perpendicular
Zwit YK-C peptides in the octameric bundle.
With the stoichiometry of Cd2+ binding established, we
sough to characterize metal ion binding affinity. The above-
discussed titration of 100 μM Zwit YK-C (where [Zwit YK-
C]bundle = 11.9 μM) with 0 to 75 μM CdCl2 was characterized
by a sigmoidal change in absorbance at 245 nm (Figure 4A).
The change in absorbance fit poorly to a simple binding model
in which two Cd2+ ions bind with no cooperativity (Figure 4A,
dashed curve); the observed binding curve is clearly sigmoidal
in shape, and not hyperbolic.
By contrast, the data provided an excellent fit to the Hill
equation (R2 = 0.99) (Figure 4A, solid curve).28 The Hill
coefficient provided by this fit, nh = 1.9 ± 0.1, suggests an
extreme difference in the affinity of the Zwit YK-C bundle for
the two metal ions, and is consistent with significant
preorganization by the first bound metal ion. The Hill equation
returns an apparent Kd of 15.3 ± 0.5 μM, representing the half-
maximal binding of Cd2+ to the bundle. We note that the
observed total absorbance at 245 nm at saturation (0.36 ±
0.008 AU) is also consistent with two-coordinate binding (two
S-ligands per Cd), as it gives an extinction coefficient for the
lowest-energy LMCT, ε245 = 14 280 M
−1 cm−1, that is
approximately twice the expected extinction coefficient of
∼6000 M−1 cm−1 per Cd−S bond.26,27 ITC analysis (Figure
4B) provided further support for the Cd2+ affinity of the Zwit-
YK-C bundle: Although the low affinity precluded the
determination of thermodynamic parameters (ΔH, TΔS),29
the ITC data could be fit with confidence to an apparent Kd
value (39 ± 3 μM) that is comparable to that determined
spectroscopically.
While the value of the Hill coefficient (nh = 1.9 ± 0.1)
implies a cooperative relationship between the two metal-
binding sites, the mechanism of this cooperativity is not well
described by the familiar concerted allosteric transition:
attempted analysis using the MWC model of allostery30
resulted in poor convergence to the data. The origin of the
observed cooperativity of metal ion binding by the Zwit YK-C
bundle thus remains unclear, and will require further study.
In summary, we here describe a cooperatively folded β-
peptide assembly that coordinates two metal ions in a specific
manner and with high positive allostery. These features should
aid the design of sophisticated molecular assemblies with
catalytic and substrate-sensing functions that have previously
not been available to de novo designed synthetic proteomi-
metics in water.
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